Brain Function Monitor Assesses Anesthetized Patients
|
By HospiMedica International staff writers Posted on 11 Oct 2021 |
|
Image: The NeuroSense NS-901 monitor (Photo courtesy of NeuroWave Systems)
A novel brain function monitor simultaneously provides independent indices of anesthetic effects for each side of the brain.
The NeuroWave Systems (Beachwood, OH, USA) NeuroSense NS-901 monitor displays bi-lateral wavelet anesthetic value for central nervous system (WAVCNS) values, thus quantifying the hypnotic effect of anesthetics for each side of the brain independently. Unlike monitoring a single index--derived from one or both hemispheres--independent bilateral monitoring allows for greater inter-hemispheric reproducibility, providing clinicians with a tool that can be used to spot hemispheric differences resulting from underlying pathologies or unrecognized artifacts.
Features include raw electroencephalograph (EEG) signals and processed EEG parameters, with automated annotations, markers, and signal quality indicators; high-resolution bilateral density spectral array and suppression ratios; automated artifact detection and removal; electro-surgical and cardiac defibrillation filtering; discernment between consciousness and unconsciousness states; review capability for both EEG tracings and processed data trends; and an intuitive touch-screen interface and case review archive, with all data transferrable to USB drive in EDF+ format.
“Our NeuroSense monitors have successfully been used in Europe over the last decade,” said Tatjana Zikov, President of NeuroWave Systems. “This next generation brain function monitor offers unique features to this space, such as an instant response, individual anesthetic depth index for each brain side, linear response to increasingly deep anesthesia, and superior discrimination between consciousness and unconsciousness.”
NeuroWave Systems is also pioneering novel systems that will automate anesthesia and sedation delivery, using vertically integrated, proprietary infusion pumps with clinically tested closed-loop control algorithms and state-of-the-art signal processing of brain waves so as to achieve continuous, automated drug delivery, based on reliable assessment of the patient brain state.
Related Links:
NeuroWave Systems
The NeuroWave Systems (Beachwood, OH, USA) NeuroSense NS-901 monitor displays bi-lateral wavelet anesthetic value for central nervous system (WAVCNS) values, thus quantifying the hypnotic effect of anesthetics for each side of the brain independently. Unlike monitoring a single index--derived from one or both hemispheres--independent bilateral monitoring allows for greater inter-hemispheric reproducibility, providing clinicians with a tool that can be used to spot hemispheric differences resulting from underlying pathologies or unrecognized artifacts.
Features include raw electroencephalograph (EEG) signals and processed EEG parameters, with automated annotations, markers, and signal quality indicators; high-resolution bilateral density spectral array and suppression ratios; automated artifact detection and removal; electro-surgical and cardiac defibrillation filtering; discernment between consciousness and unconsciousness states; review capability for both EEG tracings and processed data trends; and an intuitive touch-screen interface and case review archive, with all data transferrable to USB drive in EDF+ format.
“Our NeuroSense monitors have successfully been used in Europe over the last decade,” said Tatjana Zikov, President of NeuroWave Systems. “This next generation brain function monitor offers unique features to this space, such as an instant response, individual anesthetic depth index for each brain side, linear response to increasingly deep anesthesia, and superior discrimination between consciousness and unconsciousness.”
NeuroWave Systems is also pioneering novel systems that will automate anesthesia and sedation delivery, using vertically integrated, proprietary infusion pumps with clinically tested closed-loop control algorithms and state-of-the-art signal processing of brain waves so as to achieve continuous, automated drug delivery, based on reliable assessment of the patient brain state.
Related Links:
NeuroWave Systems
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
Gas Analyzer
GE SAM
New
Wound Irrigation Solution
Prontosan®
Latest Critical Care News
- Automated IV Labeling Solution Improves Infusion Safety and Efficiency
- First-Of-Its-Kind AI Tool Detects Pulmonary Hypertension from Standard ECGs
- 4D Digital Twin Heart Model Improves CRT Outcomes
- AI Turns Glucose Data Into Actionable Insights for Diabetes Care
- Microscale Wireless Implant Tracks Brain Activity Over Time
- Smart Mask Delivers Continuous, Battery-Free Breath Monitoring
- Routine Blood Pressure Readings May Identify Risk of Future Cognitive Decline
- CGM-Based Algorithm Enhances Insulin Dose Adjustment in Type 2 Diabetes
- Fish Scale–Based Implants Offer New Approach to Corneal Repair
- Dual-Function Wound Patch Combines Infection Sensing and Treatment
- Smartwatch Signals and Blood Tests Team Up for Early Warning on Insulin Resistance
- Smart Fabric Technology Aims to Prevent Pressure Injuries in Hospital Care
- Standardized Treatment Algorithm Improves Blood Pressure Control
- Combined Infection Control Strategy Limits Drug-Resistant Outbreak in NICU
- AI Helps Predict Which Heart-Failure Patients Will Worsen Within a Year
- Algorithm Allows Paramedics to Predict Brain Damage Risk After Cardiac Arrest
Channels
Artificial Intelligence
view channel
Machine Learning Approach Enhances Liver Cancer Risk Stratification
Hepatocellular carcinoma, the most common form of primary liver cancer, is often detected late despite targeted surveillance programs. Current screening guidelines emphasize patients with known cirrhosis,... Read more
New AI Approach Monitors Brain Health Using Passive Wearable Data
Brain health spans cognitive and emotional functions and can fluctuate even in adults without diagnosed disease. Detecting early changes remains difficult in routine care and burdens specialty services... Read more
Surgical Techniques
view channel
Continuous Monitoring with Wearables Enhances Postoperative Patient Safety
Postoperative hypoxemia on general surgical wards is common and often missed by intermittent vital sign checks. Undetected low oxygen levels can delay recovery and raise the risk of complications that... Read more
New Approach Enables Customized Muscle Tissue Without Biomaterial Scaffolds
Volumetric muscle loss is a traumatic loss of skeletal muscle that often leads to permanent functional impairment and limited reconstructive options. Current experimental strategies struggle to deliver... Read more
Patient Care
view channel
Wearable Sleep Data Predict Adherence to Pulmonary Rehabilitation
Chronic obstructive pulmonary disease (COPD) is a long-term lung disorder that makes breathing difficult and often disturbs sleep, reducing energy for daily activities. Limited engagement in pulmonary... Read more
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
Health IT
view channel
EMR-Based Tool Predicts Graft Failure After Kidney Transplant
Kidney transplantation offers patients with end-stage kidney disease longer survival and better quality of life than dialysis, yet graft failure remains a major challenge. Although a successful transplant... Read more
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read more
Business
view channel
GE HealthCare Leads Major European Initiative to Advance Cardio-Oncology Care
Cardiovascular complications are increasingly recognized among people undergoing or recovering from cancer treatment, driven by pre‑existing disease and the cardiotoxic effects of chemotherapy, radiotherapy,... Read more
